Experts have proposed renaming Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS). The change aims to clarify that the condition is a systemic hormonal and metabolic disorder, not just an ovarian issue. While supporters believe the new name will improve diagnostic accuracy and reduce stigma, critics warn that systemic healthcare reforms are still essential.